Immediate Impact
87 standout
Citing Papers
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2022 Standout
Works of C. Munichoodappa being referenced
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C. Munichoodappa | 86 | 35 | 4 | 26 | 5 | 111 | |
| Jaako Tuomilehto | 55 | 41 | 23 | 6 | 109 | ||
| Jenny Söderlund | 102 | 53 | 16 | 28 | 7 | 160 | |
| Victoria R. Trapani | 115 | 65 | 2 | 25 | 10 | 186 | |
| David S. Schade | 90 | 39 | 3 | 46 | 7 | 136 | |
| Y Makita | 41 | 47 | 68 | 16 | 6 | 178 | |
| S W Kim | 46 | 13 | 15 | 7 | 109 | ||
| Julia Cleveland | 35 | 14 | 8 | 25 | 5 | 220 | |
| Friederike Denzer | 76 | 42 | 41 | 6 | 203 | ||
| Silvia Martín | 32 | 48 | 7 | 27 | 5 | 186 | |
| P Mah | 173 | 28 | 4 | 25 | 5 | 241 |
All Works
Loading papers...